Scolaris Content Display Scolaris Content Display

Cochrane Central Register of Controlled Trials

Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection

Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Gutiérrez F, Hocqueloux L, Maggiolo F, Sandkovsky U, Granier C, Pappa K, Wynne B, Min S, Nichols G, SINGLE Investigators
Sourced from: